Virpax Pharmaceuticals

Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in non-opioid pain management therapies, has announced significant changes to its leadership team amidst ongoing litigation. The company recently …

Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman Read More

Virpax Pharmaceuticals

Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management

BERYWN, PA — In a significant move that promises to reshape the future of pain management, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its intent to submit an Investigational New …

Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management Read More

Virpax Pharmaceuticals

Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced that the cooperative research and development agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) to evaluate Virpax’s …

Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research Read More

Virpax Pharmaceuticals

Virpax Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

BERWYN, PA — Virpax Pharmaceuticals, Inc.(NASDAQ: VRPX) announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Monday, September 11th through Wednesday, September 13th starting at 7:00 a.m. …

Virpax Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference Read More